Ling Wang - Allgens Medical Head Finance
| 688613 Stock | 16.86 0.15 0.90% |
Executive
Ling Wang is Head Finance of Allgens Medical Technology
| Age | 47 |
| Phone | 86 10 5633 0938 |
| Web | https://www.allgensmed.cn |
Allgens Medical Management Efficiency
The company has return on total asset (ROA) of (0.0136) % which means that it has lost $0.0136 on every $100 spent on assets. This is way below average. Allgens Medical's management efficiency ratios could be used to measure how well Allgens Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Yuxuan Zhong | Union Semiconductor Co | 62 | |
| Xingtian Ma | Union Semiconductor Co | 59 | |
| Jun Wu | Road Environment Technology | 47 | |
| Zhihan Wu | Zhongshan Broad Ocean Motor | N/A | |
| Jing Lou | Zhongshan Broad Ocean Motor | 36 | |
| Xiao Wu | Zhongshan Broad Ocean Motor | 50 | |
| Yong Zhang | XiAn Dagang Road | N/A | |
| Bo Liu | Zhongshan Broad Ocean Motor | 37 | |
| Jian Yang | Road Environment Technology | 38 | |
| Yu Wang | Silkroad Visual Technology | 41 | |
| Jianhua Hu | Road Environment Technology | 61 | |
| Haiyan Jia | Hubei Tech Semiconductors | N/A | |
| Zhenfang Huang | Union Semiconductor Co | 61 | |
| Jing Liu | Road Environment Technology | 41 | |
| Xie Xi | Union Semiconductor Co | 34 | |
| Jin Kang | Hubei Tech Semiconductors | 58 | |
| Jianzhong Liu | Road Environment Technology | 42 | |
Management Performance
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | -0.0136 |
Allgens Medical Tech Leadership Team
Elected by the shareholders, the Allgens Medical's board of directors comprises two types of representatives: Allgens Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Allgens. The board's role is to monitor Allgens Medical's management team and ensure that shareholders' interests are well served. Allgens Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Allgens Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Guofeng Tian, Deputy Director | ||
| Ling Wang, Head Finance | ||
| Zhiye Qiu, Deputy Secretary | ||
| Gang Hu, Chairman GM | ||
| Menglong Cui, GM Director | ||
| Fuzhai Cui, Founder Scientist | ||
| Wanlan Huang, Deputy Director | ||
| Tianxi Song, Director Manager |
Allgens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Allgens Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | -0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 1.26 B | ||||
| Shares Outstanding | 135.55 M | ||||
| Shares Owned By Insiders | 41.24 % | ||||
| Shares Owned By Institutions | 2.38 % | ||||
| Price To Book | 1.59 X | ||||
| Price To Sales | 11.85 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Allgens Stock
Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.